Chop deletion preserves β-cell function in P58IPK−/− mice.

Slides:



Advertisements
Similar presentations
Sophie Croizier, Vincent Prevot, Sebastien G. Bouret  Cell Reports 
Advertisements

Figure 1 Body weight of control and BPA-treated mothers after delivery
A B Figure S1. Macroscopic analyses of the ColIITgcog mouse phenotype (female mice) (A) Graph and table of body weights and percentage differences of female.
The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.
Characterization of transgenic mice.
Argonaute2 Mediates Compensatory Expansion of the Pancreatic β Cell
Volume 15, Issue 1, Pages (January 2007)
Insulin content of isolated pancreas and islet morphology.
Volume 13, Issue 11, Pages (December 2015)
Impaired glucose tolerance in adult S1/3 KO mice on a normal chow
Volume 134, Issue 3, Pages (March 2008)
Deletion of Lats1 is phenotypically distinct from Lats2 deletion in PyMT tumors. Deletion of Lats1 is phenotypically distinct from Lats2 deletion in PyMT.
The adipose tissue of BALB/c scid mice is quantitatively, but not qualitatively, different than that of BALB/c control mice. The adipose tissue of BALB/c.
Intra‐eWAT administration of FGF21 vectors in ob/ob mice
Role of VEGF-A in Vascularization of Pancreatic Islets
Volume 22, Issue 1, Pages (July 2015)
Volume 1, Issue 4, Pages (April 2005)
Volume 15, Issue 3, Pages (April 2016)
Volume 96, Issue 3, Pages (February 1999)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis  Sarah H. Bates, Rohit N. Kulkarni, Matthew.
Volume 9, Issue 6, Pages (June 2009)
Therapeutic role of TR in HFD‐established diabetic mice
mpJX-594 effects on tumor burden and leukocyte influx.
Islet mass and β-cell proliferation is decreased in Hhip–/– embryos (Hip1 in figure). Islet mass and β-cell proliferation is decreased in Hhip–/– embryos.
Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.
Deletion of neuronal insulin receptor signaling reduces TG secretion, while the targeted knockout of insulin receptors restricted to the periphery increases.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
WASH cKO mice display a normal pancreatic development.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
GSIS. GSIS. In vivo: serum insulin levels at fasting state and 30 min after glucose injection (A) and the fold change in serum insulin after glucose loading.
PD-1, but not PD-L1, expressed by the BDC2
Insulin promoter confers β-cell–specific GFP expression in pancreas.
PMPs survive STZ cytotoxicity and produce larger colonies with a higher yield of insulin+ progeny. PMPs survive STZ cytotoxicity and produce larger colonies.
Fragment N expression does not affect islet morphology and cellularity
Zn2+ and NAD(P)H content in Mafa∆panc and Mafa∆panc;Mafb+/− β-cells.
Comparison of women carrying a male fetus and those carrying a female fetus, with respect to mean adjusted blood glucose levels during the OGTT (A), mean.
Loss of protection by linagliptin against obesity-related inflammation and insulin resistance in MIP-1α−/− mice. Loss of protection by linagliptin against.
Measurement of insulin release from islets evoked by glucose, diazoxide, and high K+. Measurement of insulin release from islets evoked by glucose, diazoxide,
Grg3 is expressed in most β-cells but less frequently in α-cells.
At 6 months of age, PPARγ deletion in late osteoblast/osteocyte controls glucose homeostasis by increasing metabolic rate and glucose uptake in WAT, BAT,
ΑGLP-1R−/− mice show glucose intolerance and disturbed glucagon secretion in response to i.p. glucose administration. αGLP-1R−/− mice show glucose intolerance.
Metformin and rapamycin decreased tumor weights in obese prediabetic mice. Metformin and rapamycin decreased tumor weights in obese prediabetic mice. A:
BAFF-deficient (BAFFnull) and anti-BAFF antibody (Ab)–treated obese mice exhibit superior glucose metabolic control compared with WT and Bnull mice. BAFF-deficient.
Insulin sensitivity in athletes and sedentary normal-weight and obese, young, and old individuals. Insulin sensitivity in athletes and sedentary normal-weight.
T1D is reduced in CT-treated NOD mice.
A: Chemical structure of pterosin A
GLP-1 and gastrin combination therapy increases pancreatic insulin content (A) and β-cell mass (B) in NOD mice. GLP-1 and gastrin combination therapy increases.
Phenotypic characterization of splenic and islet-infiltrating B-cells in 12-week-old NOD female mice. Phenotypic characterization of splenic and islet-infiltrating.
Supplementation of c-Rel–competent Treg cells reverts exacerbated diabetes in c-Rel−/− NOD mice. Supplementation of c-Rel–competent Treg cells reverts.
Atrasentan reduces albuminuria in diabetic apoE KO mice.
ChREBPα increases β-cell mitochondrial activity and ATP production in human islets. ChREBPα increases β-cell mitochondrial activity and ATP production.
Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.
Insulin resistance and hepatic steatosis in ASKO mice.
Effects of Rosi treatment on ASKO mice.
MANF expression is required for maintaining β-cell mass.
Energy stores in quadriceps muscles at rest (white bars) and after treadmill exercise (black bars) in WT and HSL KO mice. Energy stores in quadriceps muscles.
Glucose-stimulated insulin secretion, plasma glucagon levels, and pancreatic hormone contents. Glucose-stimulated insulin secretion, plasma glucagon levels,
Metabolic outcomes associated with DIO in E3FAD and E4FAD mice.
GTTs and ITTs. A: GTTs of WT (◇), LepTg (♦), Akita (open circles), and LepTg:Akita (closed circles) mice at 8 and 16 weeks of age. GTTs and ITTs. A: GTTs.
High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
β-Cell–specific deletion of Phb2 renders mice diabetic.
Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.
Increased pancreatic insulin content and islet size and protection against HFD- and palmitate-induced cell death in PKCδKN-overexpressing mice. Increased.
Chronic rapamycin treatment impairs β-cell mass and insulin clearance in rats. Chronic rapamycin treatment impairs β-cell mass and insulin clearance in.
Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic.
Pomalidomide decreases fibrosis in the lesion areas of the pancreas of KC mice. Pomalidomide decreases fibrosis in the lesion areas of the pancreas of.
The tumorous pancreas has an abundant microbiome and its ablation is protective against pancreatic disease progression. The tumorous pancreas has an abundant.
Volume 4, Issue 4, Pages (October 2006)
Presentation transcript:

Chop deletion preserves β-cell function in P58IPK−/− mice. Chop deletion preserves β-cell function in P58IPK−/− mice. A: Blood glucose was measured at the indicated times, either ad libitum or after a 5-h fast, in mice with the indicated genotypes up to 41 weeks of age (n = 7–13 mice per group). B: GTTs were performed in mice with the indicated genotypes. Glucose doses were 2 mg/kg body weight for mice 14 and 16 weeks of age and 1 mg/kg body weight for mice 36 weeks of age (n = 7–13 mice per group). Significance was shown between P58IPK−/− Chop+/− and P58IPK−/− Chop−/−. C: Pancreatic insulin was measured in mice with the indicated genotypes at 16 weeks of age (n = 4–6 mice per group). D: Islet mass was measured in pancreatic sections from 16-week-old P58IPK−/− Chop+/− or P58IPK−/− Chop−/− mice and their littermates. The percentage indicates the total islet mass over the pancreas area in each pancreata (n = 4 mice per group). E: Transmission electron microscopy was performed on pancreatic sections from P58IPK+/−Chop+/− mice and P58IPK−/−Chop−/− mice at 38–41 weeks of age. Representative images are shown. Scale bar represents 0.5 μm. All data are mean ± SEM. *P < 0.05; **P < 0.01. Jaeseok Han et al. Diabetes 2015;64:2892-2904 ©2015 by American Diabetes Association